A carregar...
New hope for chronic myelogenous leukemia patients: dasatinib offers better efficacy with shorter treatment
Although the discovery of tyrosine kinase inhibitors (TKIs) has dramatically improved the prognoses of chronic myelogenous leukemia (CML) patients, a cure has remained elusive. Unanswered questions include how long must a patient continue on TKI therapy, and how does a patient know when he/she can s...
Na minha lista:
| Publicado no: | Stem Cell Investig |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958058/ https://ncbi.nlm.nih.gov/pubmed/27488943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2016.05.05 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|